HOME / CONTACT US
繁體版 / 简体版
  • ABOUT COMPANY
    • About
    • History
    • Team
    • Global Partnership
    • Expanded Access Program
    • Nanchou Plant　▍　PIC/S GMP Manufacturing Site
    • Nanchou Plant　▍　Medicinal Herbs Cultivation
    • CEO Conversation：Founder of Oneness Biotech
  • SCIENCE
    • Pipeline
    • ON101
    • FB825
    • FB704A
    • OB318
    • FB918
    • SNS812
    • Technology
  • FESPIXON
    • Drug Information
    • About Diabetic Foot Ulcers
    • Medical Subsidies for low-Income DFU Patients
    • Patient Brochure Request
    • The Ph3 data and the mechanism of action of Fespixon（ON101） have been published on the JAMA Network Open
  • NEWS
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
  • INVESTOR
    • Company Organization
    • Corporate Governance
    • Financials
    • Shareholders’ Meeting
    • Corporate Presentation
    • Investor FAQs
  • ESG
    • ESG Report
    • Sustainability
    • Ethical Management
    • Environmental Protection
    • Social Engagement
  • CAREERS
    • Choose Oneness Biotech
    • Learning Development
    • Compensation & Benefits
    • Join us
  • ABOUT COMPANY
    • About
    • History
    • Team
    • Global Partnership
    • Expanded Access Program
    • Nanchou Plant　▍　PIC/S GMP Manufacturing Site
    • Nanchou Plant　▍　Medicinal Herbs Cultivation
    • CEO Conversation：Founder of Oneness Biotech
  • SCIENCE
    • Pipeline
    • ON101
    • FB825
    • FB704A
    • OB318
    • FB918
    • SNS812
    • Technology
  • FESPIXON
    • Drug Information
    • About Diabetic Foot Ulcers
    • Medical Subsidies for low-Income DFU Patients
    • Patient Brochure Request
    • The Ph3 data and the mechanism of action of Fespixon（ON101） have been published on the JAMA Network Open
  • INVESTOR
    • Company Organization
        • OVERVIEW Company Organization Shareholding Structure
    • Corporate Governance
        • Governance Structure Corporate Governance Supervisor Appointment Board of Directors Audit Committee Compensation Committee Risk Management Committee Committee Members Internal Audit Ethical Corporate Management Risk Management Information Security Management Intellectual Property Management Major Internal Policies
    • Financials
        • Financial Report / Financial Statements Stock Quotes
    • Shareholders’ Meeting
        • Annual Report Meeting Minutes / Meeting Agenda Meeting Notice
    • Corporate Presentation
        • Events and Presentations 2021 Q3 Online Investor Conference
    • Investor FAQs
        • Contact Us FAQs(Date)(前台暫時隱藏) FAQs(category)
    • ABOUT COMPANY
        • About History Team Global Partnership Expanded Access Program Nanchou Plant　▍　PIC/S GMP Manufacturing Site Nanchou Plant　▍　Medicinal Herbs Cultivation CEO Conversation：Founder of Oneness Biotech
    • SCIENCE
        • Pipeline ON101 FB825 FB704A OB318 FB918 SNS812 Technology
    • ESG
        • ESG Report Sustainability Ethical Management Environmental Protection Social Engagement
    • Fespixon
        • Drug Information About Diabetic Foot Ulcers Medical Subsidies for low-Income DFU Patients Patient Brochure Request The Ph3 data and the mechanism of action of Fespixon（ON101） have been published on the JAMA Network Open
    • Careers
        • Choose Oneness Biotech Learning Development Compensation & Benefits Join us
  • ESG
    • ESG Report
    • Sustainability
    • Ethical Management
    • Environmental Protection
    • Social Engagement
  • NEWS
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
  • CAREERS
    • Choose Oneness Biotech
    • Learning Development
    • Compensation & Benefits
    • Join us
  • CONTACT US
  • 繁體版
  • 简体版
　

Copyright © Oneness Biotech Co., Ltd. All Rights Reserved.